TCIRG1 and neoplasm: Knowing that immunocheckpoint inhibitors (ICIs) are a significant new group of tumor immunotherapy drugs [44], we used the TISIDB database to analyze the correlation between the expression level of TCIRG1 and ICIs in different human cancer types (Fig. 4F).